AAO research

AAO Aug192010_04B2203: Leukemia Researcher EB-1B Appeal

AAO Aug192010_04B2203: Leukemia Researcher EB-1B Appeal

Source-reviewed summary of this AAO decision, the evidence assessed, and the stated outcome.

Decision snapshot

Decision detail

Source-backed value

Decision ID

Aug192010_04B2203

Disposition stated in the source

This is an EB-1B outstanding researcher decision. The AAO accepted the beneficiary’s AML model and bone-marrow-transplant work as original contributions to hematology, but rejected the claimed membership and authorship criteria and found the judging evidence ineligible because it postdated filing and did not establish that the journal selected him to judge. Only one criterion was met, below EB-1B’s two-criterion minimum. The AAO also completed final merits and found moderate citations and a handful of inquiries insufficient to show international recognition as outstanding. Appeal dismissed.

The association memberships did not require outstanding achievements

The petitioner documented membership in ASH and AIMS. The AAO found the record did not explain how ASH evaluated applicants beyond confirming field activity/publications, and AIMS appeared to assess credentials rather than confer membership only on those with outstanding achievements. It also applied the regulation’s plural “associations” language.

Source: Aug192010_04B2203 page 5; Aug192010_04B2203 page 6.

The judging evidence was post-filing and did not establish service as a judge

The evidence was an email with comments on a manuscript sent to the beneficiary’s supervisor, plus the supervisor’s account that the comments helped prepare his own critique. The record did not show the journal requested the beneficiary’s review or that he supplied the actual review. In any event, the evidence postdated the petition filing and could not establish eligibility as of filing.

Source: Aug192010_04B2203 page 6.

Two research lines qualified as original contributions to the field

The AAO found the AML model qualified based on moderate independent citations, requests for plasmids/protocols, corroborating expert letters, and evidence that another lab reproduced the result. It also accepted the bone-marrow-transplant work based on specific testimony that the protocol helped a Chinese hospital resume its transplant program, staff training, citations, and other record evidence. The AAO distinguished contributions to the field from merely publishing articles.

Source: Aug192010_04B2203 page 6; Aug192010_04B2203 page 7; Aug192010_04B2203 page 8; Aug192010_04B2203 page 9.

Authorship did not qualify because only one article was in a journal with known international circulation

The regulation required scholarly articles in the plural. Abstracts did not count as articles. The beneficiary had one article in Blood, whose international circulation the AAO accepted. Chinese journals were electronically accessible internationally, but the AAO found that accessibility alone did not establish international circulation; therefore the record contained only one qualifying article.

Source: Aug192010_04B2203 page 9; Aug192010_04B2203 page 10.

Only one of two required criteria was met, and final merits failed

The AAO expressly found that original contributions was the sole criterion met, while EB-1B required at least two. It nevertheless explained that even if authorship qualified, the evidence did not establish international recognition as outstanding. Moderate citations and a handful of inquiries were insufficient; the research did not set the beneficiary apart through eminence and distinction. The appeal was dismissed.

Source: Aug192010_04B2203 page 10; Aug192010_04B2203 page 11.

Current framework and related reading

The decisions above are non-precedent assessments of particular records. Historical reasoning is identified as historical; consult current guidance for the present framework.

Primary sources reviewed for this article

Sources and corrections methodology